|
KIF21A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.825880E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.121600E-03 |
| Normal-vs-Stage2 |
1.304810E-01 |
| Normal-vs-Stage3 |
4.205800E-02 |
| Normal-vs-Stage4 |
1.405220E-01 |
| Stage1-vs-Stage2 |
9.115200E-01 |
| Stage1-vs-Stage3 |
7.295400E-01 |
| Stage1-vs-Stage4 |
9.667800E-01 |
| Stage2-vs-Stage3 |
8.717000E-01 |
| Stage2-vs-Stage4 |
9.682000E-01 |
| Stage3-vs-Stage4 |
8.534600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.011900E-04 |
| Normal-vs-AfricanAmerican |
1.376080E-02 |
| Normal-vs-Asian |
3.710000E-01 |
| Caucasian-vs-AfricanAmerican |
9.110600E-01 |
| Caucasian-vs-Asian |
9.507600E-01 |
| AfricanAmerican-vs-Asian |
9.094000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.179600E-04 |
| Normal-vs-Female |
2.073900E-02 |
| Male-vs-Female |
7.010800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.622550E-01 |
| Normal-vs-Extreme_Weight |
4.881800E-02 |
| Normal-vs-Obese |
1.302120E-02 |
| Normal-vs-Extreme_Obese |
1.036370E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.205600E-01 |
| Normal_Weight-vs-Obese |
4.941000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.541600E-01 |
| Extreme_Weight-vs-Obese |
8.909800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.490600E-01 |
| Obese-vs-Extreme_Obese |
7.246400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.402600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.596700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.260400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.891200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.446600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.429000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.223000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.810000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.241800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.275200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.01639999999337E-05 |
| Normal-VS-Type2 PRCC |
1.325940E-02 |
| Normal-VS-KIRP CIMP |
2.355400E-01 |
| Normal-VS-Unclassified PRCC |
8.149700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.721200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.496300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.929200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.667740E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.007600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.096300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.088300E-02 |
| Normal-vs-N1 |
7.815800E-02 |
| Normal-vs-N2 |
5.094000E-01 |
| N0-vs-N1 |
8.337000E-01 |
| N0-vs-N2 |
6.525400E-01 |
| N1-vs-N2 |
7.058200E-01 |
|
|
